cagrilintide and semaglutide 2.4 mg Semaglutide: CagriSema Weight Loss Guide Cagrilintide–semaglutide (CagriSema) versus semaglutide or

Combination therapy is typically considered for patients with inadequate glycemic control on GLP-1 monotherapy or when cost, adherence, or side effects favor adding an oral DPP-4 rather than increasing GLP-1 dose

The effects of combining HRT and GLP-1s Both hormone therapy and GLP-1s are powerful in their own respects and their individual benefits seem to complement one another

These results were deemed correlated to the increased concentration of the lipolytic 3-AR receptors, indicating the peptides may work via the beta-adrenergic pathway

MHRA Guidance and Reporting Suspected Side Effects Adverse events during a retatrutide clinical trial must be reported to the trial team and sponsor under UK Clinical Trials Regulations

doi: 10.1016/j.athplu.2022.05.004 26

GHK-Cu for Hair Loss: When applied to the scalp, GHK-Cu works to counteract follicular miniaturization, a key factor in androgenetic alopecia